C J. Van De Donk

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myeloma.

Journal: British journal of haematology

Published: August 06, 2025

Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee.

Journal: Bone marrow transplantation

Published: October 28, 2024

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

European Myeloma Network Group review and consensus statement on primary plasma cell leukemia.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 16, 2024

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 02, 2024

Treatment sequences and drug costs from diagnosis to death in multiple myeloma.

Treatment sequences and drug costs from diagnosis to death in multiple myeloma.

Journal: European journal of haematology

Published: June 29, 2023

Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab.

Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 26, 2023

Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.

Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.

Journal: The Netherlands journal of medicine

Published: October 05, 2019

Case report: persistently seronegative neuroborreliosis in an immunocompromised patient.

Case report: persistently seronegative neuroborreliosis in an immunocompromised patient.

Journal: BMC infectious diseases

Published: February 28, 2018

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

Prevention and management of adverse events of Novel agents in multiple myeloma: A consensus of the european myeloma network.

Journal: Leukemia

Published: October 10, 2017

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study.

Journal: Leukemia

Published: February 01, 2017

A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma.

A clinical update on the role of carfilzomib in the treatment of relapsed or refractory multiple myeloma.

Journal: Therapeutic advances in hematology

Published: December 02, 2016

Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Journal: International journal of laboratory hematology

Published: April 05, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026